Money Investing megathread extravaganza - Page 263

**DaFace** · 06:35 PM

A place to talk about investing stuff.

SuperBowl4 · 03-09-2020, 12:51 PM

What are the latest odds? Over/under 2,500???

**Rain Man** · 03-09-2020, 12:53 PM

Quote:

Originally Posted by Hog's Gone Fishin

only if you sell and lock in that loss

I'm riding it down and then hopefully back up again. But here's what down feels like.

via GIPHY

scho63 · 03-09-2020, 12:54 PM

Quote:

Originally Posted by displacedinMN

today sucks

How many people have been complaining that they wish they bought "XYZ" company before it ran up so much?

There are the beginnings of bargains in the market.

Also, if you were thinking of funding your Roth IRA or 401K, what a great time and at much better prices than 2 weeks ago......

Hog's Gone Fishin · 03-09-2020, 01:15 PM

I went ahead and borrowed 10K and bought oil.

Skyy God · 03-09-2020, 01:23 PM

Quote:

Originally Posted by Hog's Gone Fishin

I went ahead and borrowed 10K and bought oil.

SuperBowl4 · 03-09-2020, 01:31 PM

Quote:

Originally Posted by Hog's Gone Fishin

I went ahead and borrowed 10K and bought oil.

What's the 10K hotline?

ghak99 · 03-09-2020, 01:36 PM

Finally got into some Ford below $6.

I guess it'd be a good time to push some pencils on refinancing or even making a large purchase happen faster than planned.

BigBeauford · 03-09-2020, 01:53 PM

Quote:

Originally Posted by ghak99

Finally got into some Ford below $6.

I guess it'd be a good time to push some pencils on refinancing or even making a large purchase happen faster than planned.

Ford has a nice run in the early 2010's but they have really stagnated the past 4 years holy hell.

Strongside · 03-09-2020, 01:56 PM

I'm bag holding on Ford in at just over $6. Hoping they soar when this blows over and they get good tailwinds with the release of the Bronco and E-F150, Mach-E Mustang, etc.

If they don't, the CEO has to go.

scho63 · 03-09-2020, 02:07 PM

If Ford doesn't cut their dividend, you are in great shape.

BigBeauford · 03-09-2020, 02:09 PM

Quote:

Originally Posted by Strongside

I'm bag holding on Ford in at just over $6. Hoping they soar when this blows over and they get good tailwinds with the release of the Bronco and E-F150, Mach-E Mustang, etc.

If they don't, the CEO has to go.

Supposedly they have been showing off a truck smaller than the current ranger which has been garnering praise from the dealerships. It sounds like an actual successor to the previous ranger, and not the pile of junk currently out there. That might be what turns the tables for them. The baby bronco ain't it, and they priced the Mach - E way too high to compete with Tesla.

Halfcan · 03-09-2020, 02:26 PM

AGNPF Algernon

Phase 2 Trails

March 09, 2020 08:45 ET | Source: Algernon Pharmaceuticals
VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has made the decision to begin production of NP-120 (Ifenprodil) with a new injectable and long acting oral release formulation, in order to be prepared for new US clinical trials for COVID-19 (coronavirus) and acute lung injury (ALI).

The decision was made after a recent independent study found that Ifenprodil significantly reduced ALI and improved survivability in an animal study with Asian H5N1 infected mice by 40%. Asian H5N1 is the most lethal form of influenza known to date with an over 50% mortality rate. This compelling data, generated via a genome wide RNAi interference approach, that lead the investigators to the identification of Ifenprodil, an NMDA receptor antagonist, has been a major contributing factor in the Company’s decision.

The Company is in negotiations with a number of manufacturers and will be announcing more details on its decision shortly.

“The Company believes strongly in the potential of Ifenprodil to treat patients who have a severe acute lung injury, including people who have various forms of respiratory infections including COVID-19 (coronavirus) and influenza,” said Christopher J. Moreau CEO of Algernon Pharmaceuticals.

Algernon has filed new intellectual property rights for NP-120 (Ifenprodil) for the treatment of respiratory diseases.

About NP-120 (Ifenprodil)

NP-120 (Ifenprodil) is an N-methyl-d-aspartate (NDMA) receptor glutamate receptor antagonist specifically targeting the NMDA-type subunit 2B (Glu2NB). Ifenprodil also exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. Although the anti-fibrotic activity of Ifenprodil in IPF is not known, recent studies have suggested a link between both receptors and pathways associated with fibrosis.

Glutamate (Glu) is the main excitatory neurotransmitter which acts on glutamate receptors in the central nervous system (CNS) but overactivation of these receptors can cause several damages to neural cells including death. Recent studies show that the glutamate agonist N-methyl-d-aspartate (NMDA) can trigger acute lung injury (ALI). ALI is a direct and indirect injury to alveolar epithelial cells and capillary endothelial cell, causing diffuse pulmonary interstitial and alveolar edema and acute hypoxic respiration failure. ALI is characterized by reduced lung volume and compliance, and imbalance of the ventilation/perfusion ratio, inducing hypoxemia and respiratory distress and its severe stage (oxygen index <200) known as acute respiratory distress syndrome (ARDS). (1) Furthermore, pathological findings show that 64% of ARDS patients may have pulmonary fibrosis during convalescence (2).

NP-120 (Ifenprodil - brand name Cerocal) was initially developed by Sanofi in the 1990s in the French and Japanese markets for the treatment of circulatory disorders. The drug is genericized and sold in Japan.

RedRaider56 · 03-09-2020, 02:51 PM

Quote:

Originally Posted by BigBeauford

Supposedly they have been showing off a truck smaller than the current ranger which has been garnering praise from the dealerships. It sounds like an actual successor to the previous ranger, and not the pile of junk currently out there. That might be what turns the tables for them. The baby bronco ain't it, and they priced the Mach - E way too high to compete with Tesla.

Mach-E is Ugly As F***. Won't help matters either.

BigBeauford · 03-09-2020, 02:59 PM

Quote:

Originally Posted by RedRaider56

Mach-E is Ugly As F***. Won't help matters either.

I was really digging it, then they showed off the price and I was like...uhhh...it's still a ford.

**Rain Man** · 03-09-2020, 03:01 PM

Quote:

Originally Posted by RedRaider56

Mach-E is Ugly As F***. Won't help matters either.

Why on earth did they call it a Mustang? That's not a Mustang.

06-27-2016, 11:23 AM
DaFace Kind of a mod Join Date: Aug 2005 Location: Donkey Land Casino cash: $26899	Investing megathread extravaganza A place to talk about investing stuff. Last edited by DaFace; 02-19-2021 at 06:35 PM..
Posts: 52,558

03-09-2020, 12:51 PM	#3931
SuperBowl4 MVP Join Date: Oct 2012 Location: HERMOSA BEACH,CA Casino cash: $7364900	What are the latest odds? Over/under 2,500???
Posts: 14,147

03-09-2020, 01:15 PM	#3934
Hog's Gone Fishin Fish are scared of me Join Date: Nov 2001 Casino cash: $-159523	I went ahead and borrowed 10K and bought oil.
Posts: 40,647

03-09-2020, 01:36 PM	#3937
ghak99 MVP Join Date: Jan 2007 Location: Missouri Casino cash: $-67750	Finally got into some Ford below $6. I guess it'd be a good time to push some pencils on refinancing or even making a large purchase happen faster than planned.
Posts: 8,711

03-09-2020, 01:56 PM	#3939
Strongside Mahomes or GTFO Join Date: Feb 2012 Location: KC Casino cash: $4774282	I'm bag holding on Ford in at just over $6. Hoping they soar when this blows over and they get good tailwinds with the release of the Bronco and E-F150, Mach-E Mustang, etc. If they don't, the CEO has to go. __________________
Posts: 13,235

03-09-2020, 02:07 PM	#3940
scho63 Politically Incorrect Join Date: Feb 2009 Location: Scottsdale, AZ Casino cash: $771110	If Ford doesn't cut their dividend, you are in great shape. __________________ *"The only difference between sex for free and sex for money is that sex for free costs you a WHOLE LOT more!"* ~Redd Foxx~ ~~2018 2019 2020 20212022 2023~~ 2024 Adopt a Chief - Clark Hunt and Brett Veach "The men who drafted Patrick Mahomes"
Posts: 52,955

03-09-2020, 02:26 PM	#3942
Halfcan In Search of a Life Join Date: Aug 2005 Casino cash: $7327995	AGNPF Algernon Phase 2 Trails March 09, 2020 08:45 ET \| Source: Algernon Pharmaceuticals VANCOUVER, British Columbia, March 09, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has made the decision to begin production of NP-120 (Ifenprodil) with a new injectable and long acting oral release formulation, in order to be prepared for new US clinical trials for COVID-19 (coronavirus) and acute lung injury (ALI). The decision was made after a recent independent study found that Ifenprodil significantly reduced ALI and improved survivability in an animal study with Asian H5N1 infected mice by 40%. Asian H5N1 is the most lethal form of influenza known to date with an over 50% mortality rate. This compelling data, generated via a genome wide RNAi interference approach, that lead the investigators to the identification of Ifenprodil, an NMDA receptor antagonist, has been a major contributing factor in the Company’s decision. The Company is in negotiations with a number of manufacturers and will be announcing more details on its decision shortly. “The Company believes strongly in the potential of Ifenprodil to treat patients who have a severe acute lung injury, including people who have various forms of respiratory infections including COVID-19 (coronavirus) and influenza,” said Christopher J. Moreau CEO of Algernon Pharmaceuticals. Algernon has filed new intellectual property rights for NP-120 (Ifenprodil) for the treatment of respiratory diseases. About NP-120 (Ifenprodil) NP-120 (Ifenprodil) is an N-methyl-d-aspartate (NDMA) receptor glutamate receptor antagonist specifically targeting the NMDA-type subunit 2B (Glu2NB). Ifenprodil also exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. Although the anti-fibrotic activity of Ifenprodil in IPF is not known, recent studies have suggested a link between both receptors and pathways associated with fibrosis. Glutamate (Glu) is the main excitatory neurotransmitter which acts on glutamate receptors in the central nervous system (CNS) but overactivation of these receptors can cause several damages to neural cells including death. Recent studies show that the glutamate agonist N-methyl-d-aspartate (NMDA) can trigger acute lung injury (ALI). ALI is a direct and indirect injury to alveolar epithelial cells and capillary endothelial cell, causing diffuse pulmonary interstitial and alveolar edema and acute hypoxic respiration failure. ALI is characterized by reduced lung volume and compliance, and imbalance of the ventilation/perfusion ratio, inducing hypoxemia and respiratory distress and its severe stage (oxygen index <200) known as acute respiratory distress syndrome (ARDS). (1) Furthermore, pathological findings show that 64% of ARDS patients may have pulmonary fibrosis during convalescence (2). NP-120 (Ifenprodil - brand name Cerocal) was initially developed by Sanofi in the 1990s in the French and Japanese markets for the treatment of circulatory disorders. The drug is genericized and sold in Japan.
Posts: 43,200